loadpatents
name:-0.016112089157104
name:-0.011847019195557
name:-0.0056779384613037
CONSTANCIS; Alain Patent Filings

CONSTANCIS; Alain

Patent Applications and Registrations

Patent applications and USPTO patent grants for CONSTANCIS; Alain.The latest application filed is for "liquid guaifenesin compositions with stable extended release profiles".

Company Profile
6.11.12
  • CONSTANCIS; Alain - Chesterfield MO
  • Constancis; Alain - Lyons FR
  • Constancis; Alain - Lyon FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Liquid Guaifenesin Compositions With Stable Extended Release Profiles
App 20220133647 - DANNER; Pierre ;   et al.
2022-05-05
Cysteine composition and injection
Grant 11,045,438 - Sutterer , et al. June 29, 2
2021-06-29
Cysteine Composition And Injection
App 20210137869 - Sutterer; Angela ;   et al.
2021-05-13
Cysteine Composition And Injection
App 20200289447 - Sutterer; Angela ;   et al.
2020-09-17
Cysteine Composition And Injection
App 20200289448 - Sutterer; Angela ;   et al.
2020-09-17
Cysteine Composition And Injection
App 20200289446 - Sutterer; Angela ;   et al.
2020-09-17
Cysteine composition and injection
Grant 10,702,490 - Sutterer , et al.
2020-07-07
Cysteine composition and injection
Grant 10,543,186 - Sutterer , et al. Ja
2020-01-28
Cysteine composition and injection
Grant 10,493,051 - Sutterer , et al. De
2019-12-03
Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications
Grant RE46,686 - Bonnet-Gonnet , et al. January 30, 2
2018-01-30
Modified-release Microparticles Based On Amphiphilic Copolymer And On Active Principle(s) And Pharmaceutical Formulations Comprising Them
App 20140105993 - Constancis; Alain ;   et al.
2014-04-17
Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications
Grant 8,679,540 - Bonnet-Gonnet , et al. March 25, 2
2014-03-25
Method For The Preparation Of Nanoparticles
App 20120156257 - Drogoz; Alexandre ;   et al.
2012-06-21
Long-acting colloidal insulin formulation and its preparation
Grant 8,017,156 - Constancis , et al. September 13, 2
2011-09-13
Polymer of acrylic or methacrylic type comprising alpha-tocopherol grafts
App 20110129540 - CHAN; You-Ping ;   et al.
2011-06-02
Microparticle oral form useful for the modified release of nanoparticles
App 20100021549 - Meyrueix; Remi ;   et al.
2010-01-28
Long-acting colloidal insulin formulation and its preparation
App 20090110742 - Constancis; Alain ;   et al.
2009-04-30
Colloidal formulation of long-acting insulin and its preparation
App 20080175921 - Constancis; Alain ;   et al.
2008-07-24
Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising them
App 20080102128 - Constancis; Alain ;   et al.
2008-05-01
Cross-linked collagenic peptide for preventing post-surgical adhesions
Grant 6,790,438 - Constancis , et al. September 14, 2
2004-09-14
Organic products containing reactive thiol functions, one method for preparing same, and biomaterials containing said products
Grant 5,646,239 - Constancis , et al. July 8, 1
1997-07-08
Adhesive compositions for surgical use
Grant 5,496,872 - Constancis , et al. March 5, 1
1996-03-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed